Why the study?
Does epidural levobupivacaine 0.5% improve sensory block duration and reduce side effects compared to racemic bupivacaine 0.5% in patients undergoing lower abdominal surgery?
Does epidural levobupivacaine 0.5% improve sensory block duration and reduce side effects compared to racemic bupivacaine 0.5% in patients undergoing lower abdominal surgery?
Epidural levobupivacaine 0.5% is a safe and effective alternative to bupivacaine for lower abdominal surgeries, offering prolonged sensory block and fewer side effects.
Answers are grounded in this paper and cite their sources.
Supports preferring epidural levobupivacaine over bupivacaine for lower abdominal surgery; extends RCT evidence of prolonged block with fewer side effects.
Epidural anaesthesia is one of the regional techniques for lower abdominal, lower limb, pelvic and vascular surgeries where complications are very less compared to spinal anaesthesia. Several central nervous system and cardiovascular adverse reactions have been linked to the R (+) isomer of bupivacaine, one of the most widely used local anesthetics in clinical practice. Its levorotatory isomer, levobupivacaine was shown to have a safer pharmacological profile with less cardiotoxic and neurotoxic effects. Hence this study was undertaken in our institute, to compare the effectiveness of the recently introduced epidural Levobupivacaine with epidural Bupivacaine for anesthesia in lower abdominal surgeries. This prospective, single center parallel group, double blind study conducted over a span of 1 year with 30 patients in each group, was effective in proving that levobupivacaine can be used as a safe alternative to Bupivacaine for epidural anesthesia in lower abdominal surgeries since it provided prolonged sensory block with lesser side effects.
No takes yet. Share an insight, caveat, or question.
Shilpashri et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: